# FDA 483 - Mohnark Pharmaceuticals Inc - February 25, 2022

Source: https://www.globalkeysolutions.net/records/483/mohnark-pharmaceuticals-inc/721b5be7-e90a-4eca-9126-b822600444d3

> FDA 483 for Mohnark Pharmaceuticals Inc on February 25, 2022. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Mohnark Pharmaceuticals Inc
- Inspection Date: 2022-02-25
- Product Type: drugs
- Office Name: Office of Medical Device and Radiological Health Division II

## Related Documents

- [483 - 2022-02-25](https://www.globalkeysolutions.net/records/483/mohnark-pharmaceuticals-inc/d4fa3768-7110-4f1d-bb60-aedb84ffdb2e)

## Related Officers

- [Special Assistant](https://www.globalkeysolutions.net/people/joanne-e-king/39af2e60-385c-4023-a977-a25157b25563)
- [Lillian M Colon-McKnight](https://www.globalkeysolutions.net/people/lillian-m-colon-mcknight/ce6346b7-a006-4f84-afba-9fdda488042d)

Company: https://www.globalkeysolutions.net/companies/mohnark-pharmaceuticals-inc/532fdc82-afe5-47b5-b472-7a814e318377

Office: https://www.globalkeysolutions.net/offices/office-of-medical-device-and-radiological-health-division-ii/ae9bd439-479a-420d-9dd8-9fe1fc0863d6